Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials

por Eder, Lihi, Tony, Hans-Peter, Odhav, Satish, Agirregoikoa, Eva Galindez, Korkosz, Mariusz, Schwartzman, Sergio, Sprabery, Aubrey Trevelin, Gellett, Amanda M., Park, So Young, Bertram, Clinton C., Ogdie, Alexis
Publicado 2022

Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning

por Queiro, Rubén, Seoane-Mato, Daniel, Laiz, Ana, Agirregoikoa, Eva Galíndez, Montilla, Carlos, Park, Hye-Sang, Pinto-Tasende, Jose A., Bethencourt Baute, Juan J., Ibáñez, Beatriz Joven, Toniolo, Elide, Ramírez, Julio, García, Ana Serrano
Publicado 2022